Past News & Events

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Winter

NOT-DA-20-016: Notice of NIDA Participation in PAR-20-036 "Getting To Zero: Understanding HIV Viral Suppression and Transmission in the United States (R01 Clinical Trial Optional)":

The purpose of this Notice is to inform potential applicants that the National Institute on Drug Abuse (NIDA) is participating in PAR 20-036 "Getting To Zero: Understanding HIV Viral Suppression and Transmission in the United States (R01 Clinical Trial Optional)". The application receipt date for the PAR is Jan 7th and we would appreciate the notice reaching the investigators in time.

Finding and Characterizing HIV’s Hiding Places (January 9, 2020):

The Department of Immunology & Microbiology Bicoastal Seminar Series at Scripps Florida is hosting Jacob Estes, PhD, who will be speaking on “Finding and Characterizing HIV’s Hiding Places.” The seminar is on Thursday, January 9, 2020 at 1:00PM in W.M. Keck Foundation Amphitheater.

NIMH and NIDA RFA-MH-20-520

The “Implementation Research in HRSA Ryan White Sites: Screening and Treatment for Mental and Substance Use Disorders to Further the National “Ending the HIV Epidemic” (EHE) Goals” funding opportunity invites applications to enhance screening and treatment for mental and substance use disorders in HRSA Ryan White HIV/AIDS Program funded sites through implementation research, to advance the goals of the National "End the Epidemic" (EHE) initiative. This FOA is intended to support applications seeking to conduct definitive studies on implementation approaches to enhance screening and treatment of substance use or mental health disorders in the HRSA Ryan White HIV/AIDS Program.

Open Date: December 31, 2019

LOI Due Date: December 31, 2019

Application Due Date: January 31, 2020

NIH Funding Opportunity: RFA-DA-20-022: Assessing the Effects of Cannabinoids on HIV-Induced Inflammation (R01 Clinical Trial Optional):

The purpose of this Funding Opportunity Announcement (FOA) is to encourage basic science and preclinical research to determine the biological mechanisms underlying the effects of cannabinoids and the endocannabinoid system on HIV-associated persistent inflammation and its consequent effects on nervous system function.
LOI due date: February 11, 2020
Application due date: March 11, 2020

Spring

2020 NIMHD Health Disparities Research Institute (March 9, 2020)

The National Institute on Minority Health and Health Disparities (NIMHD) will host the Health Disparities Research Institute (HDRI) from August 3 — 7, 2020 at the NIH campus (Natcher, Building 45 conference center rooms). The HDRI aims to support the research career development of promising early-career minority health and health disparities research scientists and stimulate research in disciplines supported by health disparities science. Applications will only be accepted from extramural scientists who meet NIH’s Early Stage Investigator (ESI) eligibility criteria. For questions or more information, visit: https://nimhd.nih.gov/programs/edu-training/hd-research-institute or email HDRI@nih.gov

Funding Opportunity Announcement RFA-DK-19-019 (March 9, 2020):

The  funding opportunity announcement (FOA) seeks US domestic research projects that address how food insecurity effects HIV comorbidities, coinfections, and complications (CCCs) within the mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The approaches may address the pathways linking food insecurity and the development or exacerbation of CCCs; or they may evaluate the mechanisms whereby interventions that alleviate food insecurity improve CCCs. These mechanisms could be related to nutritional inadequacies or patient health-related behaviors.

Open Date: February 9, 2020

LOI Due Date: February 9, 2020

Application Due Date: March 9, 2020 

FY2020 CFAR Supplements

We are pleased to announce CFAR FY19 supplement opportunities. Letters of Intent (LOI) and requests are to be submitted to the SD CFAR Administrative Core (cfar@ucsd.edu) by 12:00pm on Friday, March 13. This year we have 7 topic areas of interest.

 

Up to four applications will be submitted for the following categories:

  • Methodology and Data Science of HIV
  • Increasing the Integration of Substance Abuse Services and HIV Prevention and Care
  • Impact of Food Insecurity on HIV Prevention and HIV Care
  • Human Mobility and HIV 
  • Overcoming Barriers to HIV Reservoir Clearance

 

One application each will be submitted for the following category:

  • Equipment for CFAR Core(s)

 

Please see the for more details on the above scientific areas of interest and NIH scientific contacts.

Request for Information (RFI): Interest in data and specimens from the Hemophilia Growth and Development Study (HGDS) for research on HIV-associated comorbidities, coinfections and complications

This is to let you know that the National Heart, Lung, and Blood Institute (NHLBI) has just released a Request for Information (RFI) to seek your interest in data and specimens from the Hemophilia Growth and Development Study (HGDS) for research on HIV-associated comorbidities, coinfections and complications:

https://grants.nih.gov/grants/guide/notice-files/NOT-HL-19-747.html 

All responses to this RFI must be submitted electronically to the following webpage at

https://grants.nih.gov/grants/rfi/rfi.cfm?ID=100

by March 23, 2020. The suggested response length can be up to 1000 words per question. NHLBI would like to hear from CFARs, especially those who work in pediatric settings.

The NIH Director's Awards: Funding Opportunities Available

The NIH Common Fund announces FY2020 funding opportunities for the NIH Director’s Pioneer Award, New Innovator Award, Transformative Research Award, and Early Independence Award in the High-Risk, High-Reward Research program. The program provides unique opportunities for exceptionally creative scientists to pursue highly innovative approaches to address major challenges in biomedical or behavioral research.

  • FY2020 NIH Director's Pioneer Award (DP1 - Clinical Trial Optional): RFA-RM-19-005: Supports scientists with outstanding records of creativity pursuing new research directions to develop pioneering approaches to major challenges in biomedical and behavioral research.
  • FY2020 NIH Director's New Innovator Award (DP2 - Clinical Trial Optional): RFA-RM-19-006: Supports exceptionally creative early career scientists proposing innovative and high-impact projects. Note: The NIH definition of an Early Stage Investigator now includes clinical training.
  • FY2020 NIH Director’s Transformative Research Award (R01 - Clinical Trial Optional): RFA RM-19-007: Supports individuals or teams proposing projects that are inherently risky and untested but have the potential to create or overturn fundamental paradigms.
  • FY2020 NIH Director’s Early Independence Award (DP5 - Clinical Trial Optional): RFA RM-19-008: Supports outstanding junior scientists with the intellect, scientific creativity, drive, and maturity to bypass the traditional postdoctoral training period and launch an independent research career. Applicants must have recently completed or will soon complete their doctoral degreesor clinical training and have the support and guarantee of an independent research position from a host institution.

 

UC San Diego Global Health Institute Funding Opportunities

UC San Diego’s Global Health Institute (GHI) is excited to announce multidisciplinary funding opportunities for 2020. GHI is seeking proposals for three different funding opportunities: 

  1. Research and Travel Grants for Faculty and Postdoctoral Fellows, maximum funds $10,000/research project, $1,500/person for travel. Apply here.
  2. Student Field Experience/Research Awards, maximum funds $2,000/student. Apply here.
  3. Student Intern Opportunities via the Global Health Interns Program, maximum funds $5,000/team. Apply here.

Due date: April 15, 2020

Request for Applications - Center for Medicinal Cannabis Research Grants Program

The Center for Medicinal Cannabis Research (CMCR) is seeking to fund primary and pilot cannabis-related studies that further enhance the understanding of the efficacy and adverse effects of cannabis and cannabinoids as pharmacological agents for the treatment of medical and psychiatric disorders, and their potential public health impacts. Primary project awards will be up to $825,000 in total costs ($275,000 per year) for up to three years.  Pilot awards will be up to $300,000 for two years (up to $165,000 in Year 1 and $135,000 in Year 2). Priority will be given to proposals addressing issues identified under Funding Priorities.

LOI Due Date: April 22, 2020 2 pm PDT

Application Due Date: June 1, 2020 2 pm PDT

UC Multicampus Research Programs and Initiatives (MRPI) RFP 

UC Research Initiatives in the UC Office of the President is pleased to issue the UC Multicampus Research Programs and Initiatives Request for Proposals for award year 2021. This Request for Proposals includes opportunities for both 2-year Planning/Pilot Awards and multiyear Program Awards. The MRPI opportunity is open to UC faculty and researchers in any field of research and scholarship.

LOI due date: April 22, 2020

14th Annual CFAR Social and Behavioral Sciences Research Network (SBSRN) Conference

Scientific Meeting April 16th

Ending the HIV Epidemic: The Role of Social and Behavioral Sciences

Philadelphia, PA

 

No registration fee. Please register herehttps://redcap.link/SBSRN2020

 

Wednesday, April 15th

9am- 4pm: Mentoring Day for mentees from CFARS, ARCs, & NIDA Centers

5:30pm- 7:30pm: Poster Session & Reception 

 

Thursday, April 16th

8am- 5pm: Scientific Presentations and Sessions

 

Friday, April 17th

9am- 1pm: Focused discussion group on resource sharing for CFAR, & NIMH AIDS Research Centers (ARCs), and planning future SBSRN meetings.

 

Accommodations

The Study Hotel

20 S 33rd Street

Philadelphia, PA 19104

 

Please book online using the following the link: https://reservations.travelclick.com/99716?groupID=2743283

OR call the hotel directly at 215-387-1400 and request the CFAR Social and Behavioral Sciences Research Network block.

For government rate: please call the hotel directly to make reservations and provide government ID upon check in.

*Please note the block cuts off on March 15th and we kindly ask for all reservations to be made in advance.

The California HIV/AIDS Research Program (CHRP) is pleased to announce two new Calls for Applications:

  • Implementation Science for Ending the HIV Epidemic in California: CHRP aims to award up to $3 million for HIV implementation science. The goal of these awards is to support research that has the potential for the implementation lessons to be scalable for sustained impact on the HIV epidemic in California.
  •  HIV Policy Research Centers: CHRP aims to fund two statewide HIV Policy Research Centers. The goal of the Centers is to support timely and impactful policy analyses that are responsive to policy maker and other stakeholder needs in California and that strengthen local, state and national capacity to enact HIV-relevant policies informed by objective and rigorous research.   

LOI Due date: May 15, 2020

Visit website for more details

National Cancer Institute (NCI) RFA-CA-20-016 and NOT-CA-20-022

  • HIV/AIDS and the Tumor Niche (U54) https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-20-016.html
    The purpose of this Funding Opportunity Announcement (FOA) is to advance our understanding of the role of the tumor niche or microenvironment in the risks, development, progression, and diagnosis of cancer observed in individuals with an underlying HIV infection or Acquired Immune Deficiency Syndrome (AIDS).
    Due date: April 15, 2020
  • NOSI, Use of Biological "High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers https://grants.nih.gov/grants/guide/notice-files/NOT-CA-20-022.html
    The purpose of this Notice of Special Interest (NOSI) is to continue advancing our understanding of the risks, development, progression, diagnosis, and treatment of malignancies observed in individuals with an underlying human immunodeficiency virus (HIV) infection or acquired immunodeficiency syndrome (AIDS), particularly the non-AIDS defining malignancies which are now a leading cause of death in HIV-infected individuals.
    Due date: May 7, 2020

UAB CFAR Faith and Spirituality Research Collaborative Meeting

The UAB CFAR is hosting an Inter-CFAR Faith and Spirituality Research Collaborative to advance scientific inquiry on the ways in which faith and spirituality may enhance HIV prevention, case detection, engagement in care, viral suppression, and cure through collaborations among researchers, faith-based organizations, community leaders, and public sector leaders. Registration opens March 1, 2020. Check uab.edu/cfar for more information.

When: May 19, 2020

 

 

UAB CFAR HIV In The South Working Group Meeting

The goal of the Inter-CFAR HIV in the South Working Group is to promote discover and support the evaluation and implementation of prevention and treatment programs in order to enhance health, wellness, and outcomes, and overcome health inequities in the disproportionately impacted Southern U.S. region. Registration opens March 1, 2020. Check uab.edu/cfar for more information.

When:  May 20, 2020

 

Summer

Frances K. Mercer Seminar

The HIV Institute Seminar Series and the San Diego Center for AIDS Research are pleased to present Frances K. Mercer, PhD, in seminar on Friday, June 19, at 3:30pm. This seminar will take place via Zoom in place of the regularly scheduled Journal Club meeting of the Retrovirus Seminar Series. Dr. Mercer is an Assistant Professor of Biological Sciences, California State Polytechnic University, Pomona. She will be presenting on “Trichomonas vaginalis interaction with human leukocytes.” Email cfar@ucsd.edu for more information on Zoom details.

NOSI: HIV Pre-exposure Prophylaxis (PrEP) Implementation Science in HRSA Primary Health Care Settings (Admin Supp)

NIMH is offering one-year administrative supplements in implementation science research in collaboration with a Health Resources and Services Administration (HRSA) initiative to expand HIV prevention services in selected HRSA-funded health centers. Applicants for this supplement opportunity must propose implementation science research that is non-duplicative with any planned program evaluation at the relevant HRSA-funded health center(s), and which is within the scope and relevant to the aims of the parent NIH grant. Click here for more info.

First Available Due Date: June 16, 2020

Expiration Date: July 4, 2020





Click here for past 20172018, and 2019 news.